Conventional second-line therapy
Sponsors
The First Affiliated Hospital of Nanchang University
Conditions
Colorectal Cancer (CRC)
Unknown Phase
Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
RecruitingNCT06751914
Start: 2024-09-01End: 2027-02-28Target: 10Updated: 2024-12-30
Neoantigen-loaded DC Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
RecruitingNCT06751940
Start: 2024-09-01End: 2027-02-28Target: 10Updated: 2024-12-30